GammaTile Shows Promise in Newly Diagnosed Glioblastoma
PROVIDENCE, R.I., August 18, 2026 GT Medical Technologies, Inc. announced new clinical findings suggesting that its GammaTile® targeted radiation...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PROVIDENCE, R.I., August 18, 2026 GT Medical Technologies, Inc. announced new clinical findings suggesting that its GammaTile® targeted radiation...
BOONE, N.C., July 20, 2026 Fuse Oncology has unveiled FuseRx, an innovative AI-powered prescribing and treatment-intent solution designed to...
HAYWARD, Calif., June 30, 2026 RefleXion Medical has announced the submission of a 510(k) premarket notification to the U.S....
LOUVAIN-LA-NEUVE, Belgium, June 8, 2026 IBA (Ion Beam Applications), a global leader in particle accelerator technology and proton therapy...
STRATFORD, Conn., May 8, 2026 KUBTEC Scientific has launched the XCELL® TomoRad™ x-ray irradiator, a next-generation image-guided radiotherapy (IGRT)...
